Early recognition and management of maternal sepsis in Pakista
Not Applicable
Completed
- Conditions
- Maternal sepsisPregnancy and Childbirth
- Registration Number
- ISRCTN17105658
- Lead Sponsor
- iaquat University of Medical & Health Sciences
- Brief Summary
2022 Interim results article in https://pubmed.ncbi.nlm.nih.gov/36691196/ Results of qualitative exploratory study (added 24/01/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37518083/ (added 31/07/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 400
Inclusion Criteria
1. Women who are pregnant or within 6 weeks of miscarriage, termination of pregnancy or delivery
2. Receiving inpatient health care
Exclusion Criteria
Does not meet the inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Collected using CRFs every 2 weeks throughout the intervention phase:<br>1. The proportion of patients admitted with features of sepsis who received appropriate monitoring (full set of vital sign measurements on admission recorded on MEOWS chart)<br>2. The proportion of women with suspected maternal sepsis received antibiotics within 1 hour (if required)<br>3. The proportion of women with suspected maternal sepsis receiving the FAST-M treatment bundle (including each bundle component) within 1 hour of identification of sepsis<br>4. One focus group will be conducted before the initiation of the study to adapt the tools and identify implementation approaches<br>5. A second focus group will be conducted at the end of the study as a summative evaluation of the study to identify perceptions about the success of implementation
- Secondary Outcome Measures
Name Time Method Collected using CRFs every 2 weeks throughout the intervention phase:<br>1. The proportion of women with suspected maternal sepsis referred to clinical decision-maker on the basis of abnormal vital signs records<br>2. The proportion of women with suspected maternal sepsis receiving a clinical review by a senior clinical decision-maker following their diagnosis